|Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions.|
GJ Cook, S Houston, R Rubens, MN Maisey, I Fogelman
Journal of clinical oncology 16 (10), 3375-3379, 1998
|Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice?|
F Davnall, CSP Yip, G Ljungqvist, M Selmi, F Ng, B Sanghera, ...
Insights into imaging 3 (6), 573-589, 2012
|Imaging biomarker roadmap for cancer studies|
JPB O'Connor, EO Aboagye, JE Adams, HJWL Aerts, SF Barrington, ...
Nature reviews Clinical oncology 14 (3), 169, 2017
|Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation|
GJR Cook, I Fogelman, MN Maisey
Seminars in nuclear medicine 26 (4), 308-314, 1996
|The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping|
A Zwanenburg, M Vallières, MA Abdalah, HJWL Aerts, V Andrearczyk, ...
Radiology 295 (2), 328-338, 2020
|Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer|
SA Eccles, EO Aboagye, S Ali, AS Anderson, J Armes, F Berditchevski, ...
Breast Cancer Research 15 (5), 1-37, 2013
|Quantifying tumour heterogeneity in 18 F-FDG PET/CT imaging by texture analysis|
S Chicklore, V Goh, M Siddique, A Roy, PK Marsden, GJR Cook
European journal of nuclear medicine and molecular imaging 40 (1), 133-140, 2013
|Are pretreatment 18F-FDG PET tumor textural features in non–small cell lung cancer associated with response and survival after chemoradiotherapy?|
GJR Cook, C Yip, M Siddique, V Goh, S Chicklore, A Roy, P Marsden, ...
Journal of nuclear medicine 54 (1), 19-26, 2013
|Quantitative studies of bone with the use of 18F-fluoride and 99mTc-methylene diphosphonate|
GM Blake, SJ Park-Holohan, GJR Cook, I Fogelman
Seminars in nuclear medicine 31 (1), 28-49, 2001
|Pitfalls and artifacts in 18FDG PET and PET/CT oncologic imaging|
GJR Cook, EA Wegner, I Fogelman
Seminars in nuclear medicine 34 (2), 122-133, 2004
|Normal variants, artefacts and interpretative pitfalls in PET imaging with 18-fluoro-2-deoxyglucose and carbon-11 methionine|
GJR Cook, MN Maisey, I Fogelman
European journal of nuclear medicine 26 (10), 1363-1378, 1999
|Positron emission tomography and bone metastases|
I Fogelman, G Cook, O Israel, H Van der Wall
Seminars in nuclear medicine 35 (2), 135-142, 2005
|Computed tomography and positron emission tomography in the pre-operative staging of oesophageal carcinoma|
SC Rankin, H Taylor, GJR Cook, R Mason
Clinical radiology 53 (9), 659-665, 1998
|Imaging of adrenal tumors using FDG PET: comparison of benign and malignant lesions.|
S Maurea, C Mainolfi, L Bazzicalupo, MR Panico, C Imparato, B Alfano, ...
AJR. American journal of roentgenology 173 (1), 25-29, 1999
|The role of positron emission tomography in the management of bone metastases|
GJR Cook, I Fogelman
Cancer: Interdisciplinary International Journal of the American Cancer …, 2000
|Technetium-99m-labeled HL91 to identify tumor hypoxia: correlation with fluorine-18-FDG|
GJR Cook, S Houston, SF Barrington, I Fogelman
Journal of Nuclear Medicine 39 (1), 99-103, 1998
|The use of 18 F-FDG PET/CT in colorectal liver metastases—comparison with CT and liver MRI|
G Kong, C Jackson, DM Koh, V Lewington, B Sharma, G Brown, ...
European journal of nuclear medicine and molecular imaging 35 (7), 1323-1329, 2008
|Assessment of sarcopenia and changes in body composition after neoadjuvant chemotherapy and associations with clinical outcomes in oesophageal cancer|
C Yip, V Goh, A Davies, J Gossage, R Mitchell-Hay, O Hynes, N Maisey, ...
European radiology 24 (5), 998-1005, 2014
|Non–Small Cell Lung Cancer Treated with Erlotinib: Heterogeneity of 18F-FDG Uptake at PET—Association with Treatment Response and Prognosis|
GJR Cook, ME O’Brien, M Siddique, S Chicklore, HY Loi, B Sharma, ...
Radiology 276 (3), 883-893, 2015
|Predicting response to neoadjuvant chemotherapy with PET imaging using convolutional neural networks|
PP Ypsilantis, M Siddique, HM Sohn, A Davies, G Cook, V Goh, ...
PloS one 10 (9), e0137036, 2015